These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33478421)

  • 41. Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration Initiative.
    Sithole T; Mahlangu G; Salek S; Walker S
    Ther Innov Regul Sci; 2020 Nov; 54(6):1319-1329. PubMed ID: 33258094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative.
    Giaquinto AR; Grignolo A; Liberti L; Lim JCW; Salmonson T; Sauer F; Ukwu H
    PLoS Med; 2020 Aug; 17(8):e1003092. PubMed ID: 32785224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Good manufacturing practice inspections conducted by Tanzania medicines and medical devices authority: a comparative study of two fiscal years from 2018 to 2020.
    Sangeda RZ; Ndabatinya CJ; Maganga MB; Nkiligi EA; Mwalwisi YH; Fimbo AM
    J Pharm Policy Pract; 2024; 17(1):2399722. PubMed ID: 39291054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
    Ncube BM; Dube A; Ward K
    Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The African medicines regulatory harmonization initiative: rationale and benefits.
    Ndomondo-Sigonda M; Ambali A
    Clin Pharmacol Ther; 2011 Feb; 89(2):176-8. PubMed ID: 21252936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Pivotal Role of Quality Technical Structures for Clinical Trials Oversight in the Achievement of Long-Term Capacity Strengthening Outcomes.
    Owusu Sekyere S; Škrnjug-Yudov I; Pinz A; Meyer H; Conrad C
    Front Med (Lausanne); 2022; 9():772605. PubMed ID: 35308508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community.
    Kniazkov S; Dube-Mwedzi S; Nikiema JB
    J Pharm Policy Pract; 2020; 13():71. PubMed ID: 33088577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978-2020.
    Fimbo AM; Sillo HB; Nkayamba A; Kisoma S; Mwalwisi YH; Idris R; Asiimwe S; Githendu P; Ogbuoji O; Morrison L; Bump JB; Kaale E
    PLOS Glob Public Health; 2024; 4(10):e0003241. PubMed ID: 39413119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. UK medicines regulation: responding to current challenges.
    Richards N; Hudson I
    Br J Clin Pharmacol; 2016 Dec; 82(6):1471-1476. PubMed ID: 27580254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sharing regulatory data as tools for strengthening health systems in the Region of the Americas.
    Sousa VD; Ramalho PI; Silveira D
    Rev Panam Salud Publica; 2016 May; 39(5):245-254. PubMed ID: 27706398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ICH, the GHTF, and the Future of Harmonization Initiatives.
    Tominaga T
    Ther Innov Regul Sci; 2013 Sep; 47(5):572-580. PubMed ID: 30235582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Good manufacturing practice: the role of local manufacturers and competent authorities.
    Tomić S; Filipović Sučić A; Ilić Martinac A
    Arh Hig Rada Toksikol; 2010 Dec; 61(4):425-36. PubMed ID: 21183434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Strengthening health regulation in the Americas: regulatory authorities of regional reference].
    Ojeda LP; Cristiá RP
    Rev Panam Salud Publica; 2016 May; 39(5):294-298. PubMed ID: 27706406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of the Regulatory Approval Process of Medical Devices in Ethiopia: A Mixed Sequential Explanatory Study.
    Fufa K; Marew T; Ashenef A
    Ther Innov Regul Sci; 2023 Sep; 57(5):987-996. PubMed ID: 37211582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Product Registration in Developing Countries: A Proposal for an Integrated Regional Licensing System Among Countries in Regional Economic Blocs.
    Saidu Y; De Angelis D; Aiolli S; Stefano G; Georges AM
    Ther Innov Regul Sci; 2013 May; 47(3):327-335. PubMed ID: 30231430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regionalization as an approach to regulatory systems strengthening: a case study in CARICOM member states.
    Preston C; Chahal HS; Porrás A; Cargill L; Hinds M; Olowokure B; Cummings R; Hospedales J
    Rev Panam Salud Publica; 2016 May; 39(5):262-268. PubMed ID: 27706404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.